⌘K

Home/Filings/4/0000899243-23-020117

4//SEC Filing

Fairey William 4

Accession 0000899243-23-020117

CIK 0001420565other

View on SEC.gov Company Profile

Filed

Nov 1, 8:00 PM ET

Accepted

Nov 2, 8:55 PM ET

Size

5.4 KB

Accession

0000899243-23-020117

Insider Transaction Report

Form 4

Period: 2023-10-31

AILERON THERAPEUTICS INCALRN

Director

Transactions

Award
Stock Option (right to buy)
2023-10-31+5,450→ 5,450 total
Exercise: $1.17Exp: 2033-10-30→ Common Stock (5,450 underlying)

Footnotes (1)

[F1]This option was granted October 31, 2023. The shares underlying the option are scheduled to vest over 48 equal monthly installments from October 31, 2023, subject to continued service.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

AILERON THERAPEUTICS INC

CIK 0001420565

Entity typeother

Related Parties

1

filerCIK 0001727275

Filing Metadata

Form type: 4
Filed: Nov 1, 8:00 PM ET
Accepted: Nov 2, 8:55 PM ET
Size: 5.4 KB

View on SEC.gov